Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could ...
In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants
The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.
Crain's Chicago Business5d
RFK Jr.'s next targets are companies making baby formula
Health and Human Services Secretary Robert F. Kennedy Jr. is taking on baby formula products, the latest in his sweeping ...
Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees
Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations ...
Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...
Zacks Investment Research on MSN6d
Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?
Abbott Laboratories ABT has witnessed strong momentum in the past year. Shares of the company have risen 12.7% compared with the 9% growth of the industry during the same time frame. The S&P 500 ...